tradingkey.logo

Progyny Inc

PGNY
26.960USD
+0.330+1.24%
Cierre 12/22, 16:00ETCotizaciones retrasadas 15 min
2.32BCap. mercado
41.31P/E TTM

Más Datos de Progyny Inc Compañía

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.

Información de Progyny Inc

Símbolo de cotizaciónPGNY
Nombre de la empresaProgyny Inc
Fecha de salida a bolsaOct 25, 2019
Director ejecutivoAnevski (Peter)
Número de empleados675
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 25
Dirección1359 Broadway
CiudadNEW YORK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal10018
Teléfono12128883124
Sitio Webhttps://www.progyny.com/
Símbolo de cotizaciónPGNY
Fecha de salida a bolsaOct 25, 2019
Director ejecutivoAnevski (Peter)

Ejecutivos de Progyny Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Peter (Pete) Anevski
Mr. Peter (Pete) Anevski
Chief Executive Officer, Director
Chief Executive Officer, Director
381.11K
+58.52%
Ms. Melissa Cummings
Ms. Melissa Cummings
Chief Operating Officer
Chief Operating Officer
41.67K
--
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Lead Independent Director
Lead Independent Director
32.06K
+41.26%
Mr. Geoffrey Clapp
Mr. Geoffrey Clapp
Chief Product Officer
Chief Product Officer
28.69K
--
Mr. Kevin K. Gordon
Mr. Kevin K. Gordon
Independent Director
Independent Director
23.03K
+53.50%
Mr. Roger C. Holstein
Mr. Roger C. Holstein
Independent Director
Independent Director
21.94K
+57.70%
Mr. Lloyd H. Dean
Mr. Lloyd H. Dean
Independent Director
Independent Director
19.73K
+68.59%
Ms. Cheryl M. Scott
Ms. Cheryl M. Scott
Independent Director
Independent Director
14.11K
-15.93%
Ms. Allison Swartz
Ms. Allison Swartz
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
12.49K
-6.98%
Mr. Mark S. Livingston
Mr. Mark S. Livingston
Chief Financial Officer
Chief Financial Officer
9.18K
-21.48%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Peter (Pete) Anevski
Mr. Peter (Pete) Anevski
Chief Executive Officer, Director
Chief Executive Officer, Director
381.11K
+58.52%
Ms. Melissa Cummings
Ms. Melissa Cummings
Chief Operating Officer
Chief Operating Officer
41.67K
--
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Lead Independent Director
Lead Independent Director
32.06K
+41.26%
Mr. Geoffrey Clapp
Mr. Geoffrey Clapp
Chief Product Officer
Chief Product Officer
28.69K
--
Mr. Kevin K. Gordon
Mr. Kevin K. Gordon
Independent Director
Independent Director
23.03K
+53.50%
Mr. Roger C. Holstein
Mr. Roger C. Holstein
Independent Director
Independent Director
21.94K
+57.70%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Fertility benefits services revenue
213.94M
64.27%
Pharmacy benefits services revenue
118.93M
35.73%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
332.87M
100.00%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Fertility benefits services revenue
213.94M
64.27%
Pharmacy benefits services revenue
118.93M
35.73%

Estadísticas de accionistas

Actualizado: dom., 16 de nov
Actualizado: dom., 16 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
13.63%
The Vanguard Group, Inc.
11.70%
Seidenberg (Beth C)
6.20%
Kleiner, Perkins, Caufield & Byers
5.89%
Fidelity Management & Research Company LLC
5.22%
Otro
57.36%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
13.63%
The Vanguard Group, Inc.
11.70%
Seidenberg (Beth C)
6.20%
Kleiner, Perkins, Caufield & Byers
5.89%
Fidelity Management & Research Company LLC
5.22%
Otro
57.36%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
55.82%
Investment Advisor/Hedge Fund
29.87%
Individual Investor
7.70%
Hedge Fund
6.55%
Venture Capital
6.00%
Research Firm
3.89%
Pension Fund
1.80%
Bank and Trust
0.52%
Sovereign Wealth Fund
0.12%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
749
88.02M
102.17%
-28.58M
2025Q2
750
92.53M
107.94%
-27.39M
2025Q1
761
91.24M
106.44%
-29.72M
2024Q4
736
97.21M
113.81%
-18.60M
2024Q3
721
97.59M
108.87%
-13.76M
2024Q2
700
102.42M
113.70%
-10.92M
2024Q1
684
101.40M
106.22%
-3.55M
2023Q4
667
98.10M
102.55%
-7.56M
2023Q3
653
97.93M
102.95%
-1.75M
2023Q2
657
95.12M
99.98%
-10.18M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
11.27M
13.11%
+251.02K
+2.28%
Jun 30, 2025
The Vanguard Group, Inc.
9.85M
11.46%
+1.25M
+14.59%
Jun 30, 2025
Seidenberg (Beth C)
5.35M
6.22%
+7.21K
+0.13%
May 23, 2024
Kleiner, Perkins, Caufield & Byers
5.07M
5.9%
--
--
Mar 28, 2025
Fidelity Management & Research Company LLC
3.23M
3.76%
+358.85K
+12.49%
Jun 30, 2025
State Street Investment Management (US)
2.87M
3.33%
-47.12K
-1.62%
Jun 30, 2025
Thrivent Asset Management, LLC
4.89M
5.69%
-461.69K
-8.63%
Jun 30, 2025
Fidelity Institutional Asset Management
1.48M
1.72%
+246.23K
+19.94%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.74M
2.03%
-59.01K
-3.27%
Jun 30, 2025
ArrowMark Colorado Holdings, LLC
1.89M
2.2%
-318.93K
-14.43%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Alger Weatherbie Enduring Growth ETF
3.51%
State Street SPDR S&P Health Care Services ETF
1.69%
Invesco S&P SmallCap 600 GARP ETF
1.52%
First Trust Small Cap US Equity Select ETF
1%
Invesco S&P SmallCap Health Care ETF
0.92%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.83%
First Trust Active Factor Small Cap ETF
0.64%
VictoryShares Small Cap Free Cash Flow ETF
0.56%
First Trust Small Cap Growth AlphaDEX Fund
0.52%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.49%
Ver más
Alger Weatherbie Enduring Growth ETF
Proporción3.51%
State Street SPDR S&P Health Care Services ETF
Proporción1.69%
Invesco S&P SmallCap 600 GARP ETF
Proporción1.52%
First Trust Small Cap US Equity Select ETF
Proporción1%
Invesco S&P SmallCap Health Care ETF
Proporción0.92%
Pacer US Small Cap Cash Cows Growth Leaders ETF
Proporción0.83%
First Trust Active Factor Small Cap ETF
Proporción0.64%
VictoryShares Small Cap Free Cash Flow ETF
Proporción0.56%
First Trust Small Cap Growth AlphaDEX Fund
Proporción0.52%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción0.49%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Progyny Inc?

Los cinco principales accionistas de Progyny Inc son:
BlackRock Institutional Trust Company, N.A. posee 11.27M acciones, lo que representa el 13.11% del total de acciones.
The Vanguard Group, Inc. posee 9.85M acciones, lo que representa el 11.46% del total de acciones.
Seidenberg (Beth C) posee 5.35M acciones, lo que representa el 6.22% del total de acciones.
Kleiner, Perkins, Caufield & Byers posee 5.07M acciones, lo que representa el 5.90% del total de acciones.
Fidelity Management & Research Company LLC posee 3.23M acciones, lo que representa el 3.76% del total de acciones.

¿Cuáles son los tres principales tipos de accionista de Progyny Inc?

Los tres principales tipos de accionista de Progyny Inc son:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Seidenberg (Beth C)

¿Cuántas instituciones poseen acciones de Progyny Inc (PGNY)?

A fecha de 2025Q3, 749 instituciones poseen acciones de Progyny Inc, con un valor de mercado combinado de aproximadamente 88.02M, lo que representa el 102.17% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en -5.77%.

¿Cuál es la mayor fuente de ganancias de Progyny Inc?

El FY2025Q2, el segmento empresarial Fertility benefits services revenue generó la ganancia más alta para Progyny Inc, ascendiendo a 213.94M y representando el 64.27% de la ganancia total.
KeyAI